177 related articles for article (PubMed ID: 6687966)
1. [Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone].
Abdyldaev RA; Kruglova GV
Vopr Onkol; 1983; 29(4):83-5. PubMed ID: 6687966
[TBL] [Abstract][Full Text] [Related]
2. Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.
Sonneveld P; Hop W; Mulder AH; Michiels JJ; Blijham G; van de Lelie J; Raemakers JW; Nieuwenhuis K; van der Heul C
Semin Hematol; 1994 Apr; 31(2 Suppl 3):9-12. PubMed ID: 8073309
[No Abstract] [Full Text] [Related]
3. Cyclophosphamide, epirubicin, vincristine, and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
Comella P; Abate G; Fiore M; Di Finizio G; Zarrilli D
J Chemother; 1989 Jul; 1(4 Suppl):1257-8. PubMed ID: 16312856
[No Abstract] [Full Text] [Related]
4. [Polychemotherapy of lymphosarcoma by the COP program].
Abdullaev RA; Poddubnaia IV; Shramko AF
Sov Med; 1984; (7):103-6. PubMed ID: 6385297
[No Abstract] [Full Text] [Related]
5. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
Blayney DW; McGuire BW; Cruickshank SE; Johnson DH
Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
[TBL] [Abstract][Full Text] [Related]
6. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
Kosmas C; Malamos NA; Antonopoulos MJ
N Engl J Med; 1998 Nov; 339(20):1476; author reply 1477. PubMed ID: 9841319
[No Abstract] [Full Text] [Related]
7. [Therapy against relapse in generalized lymphoblastic and immunoblastic lymphosarcomas in complete remission].
Mustiatsé LZ; Korchmaru IF
Ter Arkh; 1986; 58(6):110-2. PubMed ID: 3764703
[TBL] [Abstract][Full Text] [Related]
8. [C-MOPP therapy in advanced diffuse lymphoma, large cell type (LSG)].
Ino T; Okamoto M; Shinkai K; Kojima H; Maruyama F; Sobue R; Ito N; Imura H; Takada T; Morikawa K
Rinsho Ketsueki; 1987 Jun; 28(6):839-44. PubMed ID: 3669323
[No Abstract] [Full Text] [Related]
9. [A comparative trial of C-novantrone OP(CNOP) vs C-adriamycin OP(CHOP) in the treatment of stage II-IV malignant lymphoma--the preliminary report].
Chuang MW; Tzeng CH; Chiou TJ; Chiu CF; Hsieh RK; Liu JH; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 1988 Jan; 41(1):51-6. PubMed ID: 3167650
[No Abstract] [Full Text] [Related]
10. Stage I and II non-Hodgkin's lymphoma: results of combined of THP-COP chemotherapy and radiotherapy.
Ohga S; Nakamura K; Shioyama Y; Sasaki T; Urashima Y; Terashima H; Honda H
Radiat Med; 2005 May; 23(3):156-61. PubMed ID: 15940061
[TBL] [Abstract][Full Text] [Related]
11. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
[TBL] [Abstract][Full Text] [Related]
12. [Possibilities of using polychemotherapy according to the COP protocol in lymphosarcoma of the gastrointestinal tract].
Poddubnaia IV
Ter Arkh; 1985; 57(2):103-6. PubMed ID: 3890247
[TBL] [Abstract][Full Text] [Related]
13. [Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients].
Izumi T; Muroi K; Hoshino Y; Komatsu N; Ohtsuki T; Yamada M; Tomizuka H; Hatake K; Furusawa S; Miura Y
Gan To Kagaku Ryoho; 1996 May; 23(6):797-800. PubMed ID: 8645033
[No Abstract] [Full Text] [Related]
14. [Comparison of effectiveness of adriamycin and epirubicin administered in the CHOP protocol to patients with malignant non-hodgkin's lymphoma].
Rolski J; Koralewski P; Pawlicki M
Wiad Lek; 1993 May; 46(9-10):356-9. PubMed ID: 8236992
[TBL] [Abstract][Full Text] [Related]
15. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
Mounier N; Gisselbrecht C; Lepage E
N Engl J Med; 1998 Nov; 339(20):1476; author reply 1477. PubMed ID: 9841320
[No Abstract] [Full Text] [Related]
16. New aspects in the treatment of advanced low-grade non-Hodgkin's lymphomas: prednimustine/mitoxantrone versus cyclophosphamide/vincristine/prednisone followed by interferon alfa versus observation only--a preliminary update of the German Low-Grade Lymphoma Study Group.
Hiddemann W; Unterhalt M; Koch P; Nahler M; Herrmann R
Semin Hematol; 1994 Apr; 31(2 Suppl 3):32-5. PubMed ID: 8073307
[No Abstract] [Full Text] [Related]
17. Deferral of initial therapy for advanced indolent lymphomas.
Portlock CS
Cancer Treat Rep; 1982 Mar; 66(3):417-9. PubMed ID: 7037178
[No Abstract] [Full Text] [Related]
18. Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone.
Bagley CM; Devita VT; Berard CW; Canellos GP
Ann Intern Med; 1972 Feb; 76(2):227-34. PubMed ID: 5066691
[No Abstract] [Full Text] [Related]
19. [Gastrointestinal lymphomas: results of multimodal therapy in 57 patients of one center].
Kiene J; Sezer O; Rasche H; Klempa I
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():244-6. PubMed ID: 9101844
[TBL] [Abstract][Full Text] [Related]
20. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
